In the VEST trial: are we missed to address the pathology incurred by the external stent?

In the VEST IV trial, the author concluded that external stenting of saphenous vein graft mitigates its remodeling and also significantly reduces the diffuse intimal hyperplasia and development of lumen irregularities at 4.5 years after coronary artery bypass grafting surgery. We also have valuable...

Descripción completa

Detalles Bibliográficos
Autores principales: Palanisamy, Vijayanand, Kurian, Valikapthalil Mathew, sethuratnam, Rajan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425144/
https://www.ncbi.nlm.nih.gov/pubmed/34496907
http://dx.doi.org/10.1186/s13019-021-01640-6
_version_ 1783749799095304192
author Palanisamy, Vijayanand
Kurian, Valikapthalil Mathew
sethuratnam, Rajan
author_facet Palanisamy, Vijayanand
Kurian, Valikapthalil Mathew
sethuratnam, Rajan
author_sort Palanisamy, Vijayanand
collection PubMed
description In the VEST IV trial, the author concluded that external stenting of saphenous vein graft mitigates its remodeling and also significantly reduces the diffuse intimal hyperplasia and development of lumen irregularities at 4.5 years after coronary artery bypass grafting surgery. We also have valuable a suggestion in addition to external stenting that might nullify the pathology caused by the stent and might enhances graft patency.
format Online
Article
Text
id pubmed-8425144
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84251442021-09-10 In the VEST trial: are we missed to address the pathology incurred by the external stent? Palanisamy, Vijayanand Kurian, Valikapthalil Mathew sethuratnam, Rajan J Cardiothorac Surg Letter to the Editor In the VEST IV trial, the author concluded that external stenting of saphenous vein graft mitigates its remodeling and also significantly reduces the diffuse intimal hyperplasia and development of lumen irregularities at 4.5 years after coronary artery bypass grafting surgery. We also have valuable a suggestion in addition to external stenting that might nullify the pathology caused by the stent and might enhances graft patency. BioMed Central 2021-09-08 /pmc/articles/PMC8425144/ /pubmed/34496907 http://dx.doi.org/10.1186/s13019-021-01640-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Palanisamy, Vijayanand
Kurian, Valikapthalil Mathew
sethuratnam, Rajan
In the VEST trial: are we missed to address the pathology incurred by the external stent?
title In the VEST trial: are we missed to address the pathology incurred by the external stent?
title_full In the VEST trial: are we missed to address the pathology incurred by the external stent?
title_fullStr In the VEST trial: are we missed to address the pathology incurred by the external stent?
title_full_unstemmed In the VEST trial: are we missed to address the pathology incurred by the external stent?
title_short In the VEST trial: are we missed to address the pathology incurred by the external stent?
title_sort in the vest trial: are we missed to address the pathology incurred by the external stent?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425144/
https://www.ncbi.nlm.nih.gov/pubmed/34496907
http://dx.doi.org/10.1186/s13019-021-01640-6
work_keys_str_mv AT palanisamyvijayanand inthevesttrialarewemissedtoaddressthepathologyincurredbytheexternalstent
AT kurianvalikapthalilmathew inthevesttrialarewemissedtoaddressthepathologyincurredbytheexternalstent
AT sethuratnamrajan inthevesttrialarewemissedtoaddressthepathologyincurredbytheexternalstent

Ejemplares similares